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Microglia and astrocytes can quench metal toxicity to maintain tissue homeostasis, but
with age, increasing glial dystrophy alongside metal dyshomeostasis may predispose the
aged brain to acquire neurodegenerative diseases. The aim of the present study was to
investigate age-related changes in brain metal deposition along with glial distribution in
normal C57Bl/6J mice aged 2-, 6-, 19- and 27-months (n = 4/age). Using synchrotron-
based X-ray fluorescence elemental mapping, we demonstrated age-related increases
in iron, copper, and zinc in the basal ganglia (p< 0.05). Qualitative assessments revealed
age-associated increases in iron, particularly in the basal ganglia and zinc in the white
matter tracts, while copper showed overt enrichment in the choroid plexus/ventricles.
Immunohistochemical staining showed augmented numbers of microglia and astrocytes,
as a function of aging, in the basal ganglia (p < 0.05). Moreover, qualitative analysis of
the glial immunostaining at the level of the fimbria and ventral commissure, revealed
increments in the number of microglia but decrements in astroglia, in older aged mice.
Upon morphological evaluation, aged microglia and astroglia displayed enlarged soma
and thickened processes, reminiscent of dystrophy. Since glial cells have major roles
in metal metabolism, we performed linear regression analysis and found a positive
association between iron (R2 = 0.57, p = 0.0008), copper (R2 = 0.43, p = 0.0057),
and zinc (R2 = 0.37, p = 0.0132) with microglia in the basal ganglia. Also, higher levels
of iron (R2 = 0.49, p = 0.0025) and zinc (R2 = 0.27, p = 0.040) were correlated to
higher astroglia numbers. Aging was accompanied by a dissociation between metal and
glial levels, as we found through the formulation of metal to glia ratios, with regions of
basal ganglia being differentially affected. For example, iron to astroglia ratio showed
age-related increases in the substantia nigra and globus pallidus, while the ratio was
decreased in the striatum. Meanwhile, copper and zinc to astroglia ratios showed a
similar regional decline. Our findings suggest that inflammation at the choroid plexus,
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part of the blood-cerebrospinal-fluid barrier, prompts accumulation of, particularly,
copper and iron in the ventricles, implying a compromised barrier system. Moreover,
age-related glial dystrophy/senescence appears to disrupt metal homeostasis, likely due
to induced oxidative stress, and hence increase the risk of neurodegenerative diseases.
Keywords: synchrotron radiation-based X-ray fluorescence elemental mapping, microglia, astrocytes, iron,
copper, zinc, aging, glial dystrophy
INTRODUCTION
Trace metals are essential for biochemical and physiological
processes as components of various vitamins, enzymes, and
cofactors (Li et al., 2017). Iron is present in copious amounts
in the brain, performing pleiotropic functions including
neurotransmitter synthesis, neuronal myelination and adenosine
triphosphate (ATP) synthesis (Ashraf et al., 2018). Other metals
such as copper, zinc and calcium are required alongside iron for
modulation of synaptic activity and neuronal plasticity (Popescu
and Nichol, 2011; Wang et al., 2012; Braidy et al., 2017; Li
et al., 2017). Their balance within the brain is regulated in a
complex fashion by brain-barrier systems (blood-brain-barrier,
BBB; blood-cerebrospinal fluid-barrier, BCSFB) and glial cells in
the CNSmilieu. Also, glial cells, i.e., microglia and astrocytes, can
sequester metals to protect neurons from metal-induced toxicity
(Bishop et al., 2011). Astrocytes appear to have a central role
in attenuating neural excitotoxicity by scavenging metals that
cross brain-barrier defenses, with microglia also partaking in
the immunity against metal accumulations (Zheng et al., 2010;
Morales et al., 2017).
Since aging is characterized by perturbed permeability
of brain-barriers and glial dystrophy/senescence, brain metal
concentration, which would otherwise be kept within narrow
limits, becomes dysregulated (Bishop et al., 2011; Popescu and
Nichol, 2011; Rathore et al., 2012; Braidy et al., 2017). The
altered compositions of trace metals may induce oxidative
stress and contribute to advanced age, being the major risk
factor for neurodegenerative diseases including Alzheimer’s
and Parkinson’s disease (PD; Popescu et al., 2009; Popescu
and Nichol, 2011; Grochowski et al., 2019). The analysis of
metal content, in terms of their age-related accumulation
in different brain regions, may be useful for monitoring
the changes accompanying normal and abnormal aging, and
provide avenues for maintaining optimal brain health. While
there have been many reports indicating brain iron increases
with aging between different regions, some have used bulk
measurements of tissue samples from different areas rather than
by spatial iron mapping (Markesbery et al., 1984); others by
histochemical Perl’s staining which is not quantitative (Connor
et al., 1990; Benkovic and Connor, 1993; Burdo et al., 1999);
and some are based on relaxometry or quantitative susceptibility
mapping MRI measurements which indirectly assessed iron by
its effects on the surrounding protons (Langkammer et al., 2012).
Most notably, none to our knowledge have spatially mapped
transition metals at reasonably high resolutions throughout
the life-course of a normally aging organism. Therefore, the
aim of this study was to examine brain metal levels using
synchrotron-radiation X-ray fluorescence (SRXRF) elemental
mapping over the normal aging life-course of C57Bl/6J mice at
2-, 6-, 19- and 27-months, corresponding to ‘‘post-adolescence,
young adults, elderly and very elderly,’’ respectively. Assessment
of microglia and astrocytes by ionized calcium binding adaptor
molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP)
immunohistochemistry (IHC), respectively, was also performed.
We have focussed on the basal ganglia which we and others
have demonstrated to accumulate iron with aging (Aquino
et al., 2009; Walker et al., 2016). We have previously reported
the quantitative assessments of iron; and ferritin-, Iba1- and
GFAP-immunopositive cells in the basal ganglia at these ages
(Walker et al., 2016). Here, we have extended the study/re-
analyzed the data to include both qualitative and quantitative
assessments of other metals, and particularly focussed on
investigating the relationships between metals and ferritin-,
Iba1- and GFAP-immunopositive cells in the basal ganglia.
Additionally, metal contents from the ventral hippocampus
and the cingulate cortex are also included in this study,
as these regions are routinely affected in normal aging and
neurodegenerative diseases.
MATERIALS AND METHODS
Animals
Male C57BL/6J mouse brains were obtained from Shared Aging
Research Models (ShARM, Sheffield, UK). Mice were culled at
2-, 6-, 19- and 27-months of age (n = 4/age) by rising CO2
inhalation. Ages of mice chosen for study were comparable
to different stages of life from just post-adolescence, adult,
midlife, elderly and the very elderly. The heads were removed
from the body and heads fixed in 4% paraformaldehyde for
1 week. The brains were then dissected out of the skulls and
brains stored in phosphate-buffered saline (PBS, 4◦C) with
0.05% sodium azide prior to cryosectioning for SRXRF and
IHC (see below). Ethical approval was not required for this
study according to the Animals (Scientific Procedures) Act
1986 (ASPA).
Brain Cryosectioning
Brains were cryoprotected in 30% sucrose in PBS with 0.05%
sodium azide and then cryosectioned coronally to produce
40 µm thick frozen sections that were mounted onto 4 µm
thick Ultralene film (Spex Sample-Prep, NJ, USA) secured
to a customized holder for SRXRF. Adjacent 20 µm thick
cryosections sections were also obtained and mounted onto
Superfrost plus microscope slides for IHC.
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SRXRF Elemental Mapping and Analysis
SRXRF of the whole/right hemisphere of brain tissue sections
was performed at the Diamond Light Source synchrotron
radiation facility (microfocus beamline I18; Didcot, UK). Brain
sections were mounted at a 45◦ angle with respect to the
incoming X-ray beam and the detector to minimize scatter
contribution and scanned raster fashion using a beam with
a diameter (resolution) of 100 µm and 11 keV energy. Full
energy dispersive spectra were collected for each sample point
exposed to the beam, fitted, and the net peak areas of the
characteristic peaks of iron, zinc, and copper (Supplementary
Table S1) were evaluated using PyMca (Solé et al., 2007). The
photon flux on the samples, required for quantification was
estimated by measurement of a reference metal film (AXO,
Dresden, GmbH). SRXRF elemental maps of pixel-by-pixel
elemental metal concentrations (parts per million, ppm) were
obtained. Regions of interest (ROIs) were placed on the elemental
metal maps to obtain average concentrations in brain regions:
substantia nigra (Bregma −3.08 to −3.64 mm), globus pallidus
(Bregma −0.22 to −0.70 mm), striatum (Bregma +1.10 mm to
+0.14), cingulate cortex (Bregma +1.10 to +0.26 mm) and ventral
hippocampus (Bregma−2.80 to−3.52 mm).
Immunohistochemistry
Standard diaminobenzidine (DAB)-IHC was performed. Firstly,
endogenous peroxidase activity was blocked by incubation with
1% hydrogen peroxide in tris-buffered saline (pH 7.4) containing
0.2% Triton X-100 (TBS+; 30 mins, ambient temperature).
Following 5 mins × 2 washes in TBS+, non-specific binding was
blocked using 10% skimmed milk powder (SMP) in TBS+ (2 h,
ambient temperature). Then the sections were incubated with
either rabbit anti-ferritin polyclonal antibody (F6136, against
ferritin light and heavy chains; Sigma-Aldrich, Poole, Dorset,
UK), rabbit polyclonal anti-Iba1 antibody (019–19741; Wako
Pure Chemical Industries, Richmond, VA, USA), or rabbit
polyclonal anti-GFAP antibody (DAKO, High Wycombe, UK)
in 5% SMP in TBS+ (overnight, 4◦C). After washes in TBS+,
slides were incubated with secondary biotinylated anti-rabbit IgG
(1:200, DAKO) in 5% SMP in TBS+ (2 h, ambient temperature).
The avidin-biotin binding was then performed using the ELITE
ABC kit (Vector, Peterborough, UK) prior to the chromogenic
reaction using the Impact DAB peroxidase kit (Vector). Finally,
after dehydration in ascending grades of ethanol, slides were
cleared in xylene and mounted using DPX (Sigma-Aldrich).
Four sections from the whole/right hemisphere including the
striatum, globus pallidus, substantia nigra, ventral hippocampus
and cingulate cortex were scanned (digitized) on a LEICA
SCN400F scanner to produce 20× magnification digital images.
Depending on the region, 2–4 optical fields were taken, each
comprising a 628.0 × 278.5 µm2 area. Ferritin-, GFAP- or
Iba1-immunopositive cells in each optical field were manually
counted using the cell counter plugin of ImageJ (NIH) and
expressed as a number of immunopositive cells per unit area.
Statistical Analysis
Data analysis was performed using Prism version 8 (GraphPad
Software, CA, USA). Normal distribution was checked
graphically using Q-Q plots, residual plot, homoscedasticity
plot, and numerically using Shapiro-Wilk’s test. The following
variables were log-transformed to normality: iron, zinc,
copper, microglia, astrocytes, and ferritin. Analysis of variance
(ANOVA) was used to determine differences between the
different regions of the brain, and at different mouse brain
ages. We also performed linear regression modeling to assess
the association between metals and glia. Metals to glia ratio
were computed to assess how the ratios changed relative to
one another with aging. A statistical value of p ≤ 0.05 was
considered significant. Values are quoted as mean ± standard
deviation (SD).
RESULTS
Qualitative Assessments
SRXRF Elemental Mapping of Metal Distributions in
the Brain
Metal distributions in the basal ganglia, cingulate cortex, and
ventral hippocampus, were mapped with SRXRF and found to
be both heterogeneous and altered with aging (Figures 1–3).
Qualitative assessment of iron revealed increased deposition in
the basal ganglia in 19- and 27-month-old mice, compared to
the younger age-groups. Interestingly, the stria medullaris of the
thalamus, fornix and the ventricles showed some qualitative iron
increments at 19- and 27-months of age especially at the latter
age (Figure 2).
Copper was strikingly enriched in the choroid
plexus/ventricles at 19- and 27-months of age (Figure 2).
Zinc, on the other hand, appeared generally elevated throughout
the brain but particularly in the stria medullaris of the thalamus,
the corpus callosum, fornix and hippocampal fissure at 19- and
27-months (Figure 2).
Immunohistochemistry of Glia Distribution
Microglial (Iba1) immunostaining at the level of fimbria and
ventral commissure appeared to be lower in 6-month-old mice
compared to those at 2-month, but higher at ages 19- and
27-months relative to younger mice (Figure 4A). On the
contrary, astrocytes (GFAP) seemed to show an age-related
decline at the fimbria/ventral commissure level (Figure 4B).
Since age is routinely associated with glial dystrophy, we
performed a qualitative evaluation of aged glia compared to
younger glia in the basal ganglia (Figure 4). Aged microglia
(27-month) exhibited signs of hypertrophy, with enlarged
soma compared to 2-month-old mice in the substantia nigra
and striatum (Figure 4Ci). The cell body of aged microglia
exhibited a spheroid shape that was distinctive from the round
shape of young microglia. Equally, the microglial processes
observed in 27-month-old mice were shorter and thickened
compared to the thinly ramified processes apparent in the
2-month old mice. Also, aged microglia commonly clustered
together and was accompanied by frequent fragmentation of
processes (Figure 4Cii).
Aged astrocytes exhibited hypertrophy, somata were larger
and more elongated with processes appearing shorter and
thicker, reminiscent of loss of distal processes (Figure 4Di).
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FIGURE 1 | Synchrotron-radiation X-ray fluorescence (SRXRF) elemental iron, copper and zinc maps of tissue sections (30 µm thick) for quantification of the
striatum of C57Bl/6J mice at 2, 6, 19 and 27-months of age. Other brain structures of interest are also labeled on the maps. High signal intensity artefacts arising
from folded tissues and specks/pieces of tissue from cryosectioning are visible in some images.
FIGURE 2 | SRXRF elemental iron, copper and zinc maps of tissue sections (30 µm thick) for quantification of globus pallidus and cingulate cortex of C57Bl/6J
mice at 2, 6, 19 and 27-months of age. Other brain structures of interest are also labeled on the maps. High signal intensity artefacts arising from folded tissues and
specks/pieces of tissue from cryosectioning are visible in some images.
Younger astrocytes were marked by manifold long processes to
serve a greater territory (Figure 4Dii).
Quantitative Assessments
SRXRF Assessment of Brain Metals
Regional Brain Concentrations
ROIs were used to probe the metal concentrations in the
basal ganglia, cingulate cortex and the ventral hippocampus
(Supplementary Figure S1). Iron distribution was similar
between different brain areas at age 2-month (Supplementary
Figure S2i). However, at 6-months of age, significantly
higher iron content was observed in the substantia nigra
(p < 0.01) and globus pallidus (p < 0.05), compared to
the cingulate cortex and ventral hippocampus. A similar
trend was observed in 19- and 27-months old mice, where,
significantly augmented iron concentrations were observed in
the substantia nigra (p < 0.05 and p < 0.001, respectively) and
globus pallidus (p < 0.001) compared to the striatum, cortex,
and hippocampus.
The copper concentration was significantly lower in the
globus pallidus compared to the striatum (p < 0.01), cingulate
(p < 0.01) and ventral hippocampus (p < 0.05) at 6-months,
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FIGURE 3 | SRXRF elemental iron, copper and zinc maps of tissue sections (30 µm thick) for quantification of substantia nigra and ventral hippocampus of one
hemisphere, of C57Bl/6J mice at 2, 6, 19 and 27-months of age. High signal intensity artifacts arising from folded tissues and specks/pieces of tissue from
cryosectioning are visible in some images. High signal intensity artefacts arising from folded tissues and specks/pieces of tissue from cryosectioning are visible in
some images. *The tissue sections collected from mice 27-month-old were not fully scanned by SRXRF to minimize scan time.
but not observed at other ages (Supplementary Figure S2ii).
Zinc levels were significantly elevated in the globus pallidus and
hippocampus compared to the substantia nigra at 2-months of
age (p< 0.05), but were lower in the globus pallidus compared to
the nigra (p < 0.05) at 6-months (Supplementary Figure S2iii),
with no changes observed at later ages.
Alterations of Regional Brain Metal Concentrations With
Aging
With advancing age, at ages 19- and 27-months, iron
concentrations were significantly increased compared to 2-
and 6-month-old mice (Figure 5i), in the substantia nigra
(p < 0.001, p < 0.05, respectively), globus pallidus (p < 0.001)
and striatum (p < 0.01, p < 0.001, respectively). In the
cingulate cortex, iron-enrichment was observed in the 19- and
27-months old mice, compared to both 2- and 6-months old
mice (p < 0.05), but were comparable between ages in the
ventral hippocampus.
Higher levels of copper were found at 19-month (p < 0.05)
and 27-month (p < 0.01) compared to 6-months old mice in
the globus pallidus (Figure 5ii). Zinc levels were augmented
in the 6-month-old mice compared to mice aged 2-months
in the substantia nigra (p < 0.05) and cingulate cortex
(p < 0.05; Figure 5iii). The globus pallidus exhibited
increased zinc at aged 27-months (p < 0.05) compared to
mice at 6-months.
Immunohistochemical Assessments of Ferritin,
Microglia and Astrocytes in the Basal Ganglia
Regional Numbers of Ferritin-, Microglia- and Astrocyte-
Immunopositive Cells
IHC revealed ferritin-immunoreactive cells (Figure 6A) to
be significantly enriched in the substantia nigra and globus
pallidus compared to the striatum at age 2-months (p < 0.01),
however, only the globus pallidus (p < 0.05) had significantly
more ferritin-immunopositive cells compared to the striatum
at 6-months (Supplementary Figure 3i). A higher number
of ferritin-immunoreactive cells (p < 0.001) was observed in
the substantia nigra relative to both the globus pallidus and
striatum at older ages (19- and 27-months). Also, the striatum
demonstrated higher numbers of ferritin-immunoreactive
cells compared to the globus pallidus at 19-months
of age (p< 0.001).
Interestingly, IHC for Iba1 did not reveal significant
differences in microglial positivity between the brain regions
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FIGURE 4 | Immunohistochemically stained images of (A) Iba1-stained microglia and (B) glial fibrillary acidic protein (GFAP)-stained astroglia acquired at the level of
the hippocampal fimbria and ventral commissure (20× magnification, scale bar = 100 µm). (Ci) The images show differences in Iba1-immunopositive microglia
morphology in the basal ganglia, in 2-months old C57Bl/6J with microglia having small soma and ramified processes, compared to hypertrophic cell bodies and
thickened processes (arrows) at 27-months of age (40× magnification, scale bar = 40 µm). (Cii) Fragmentation of processes is demonstrated by microglial staining
in the basal ganglia of 27-month-old C57Bl/6J mice (40× magnification, scale bar = 40 µm). (Di) GFAP-stained astrocytes in 2-months old C57Bl/6J mice exhibit a
small cell body with long, thin primary processes, while at 27-months of age, astrocytes show a spheroid cell body and thickened processes with a loss of distal
processes (40× magnification, scale bar = 40 µm). (Dii) astrocytes in 2-month-old C57Bl6/J mice show manifold processes and therefore serve a greater territory,
while those in 27-month-old mice exhibit loss of distal processes, de-ramified processes that have become shorter and thickened (40× magnification, scale
bar = 40 µm).
at different ages (Supplementary Figure S3ii). On the other
hand, GFAP IHC revealed a consistent pattern of significant
differences between the regions at all ages, with higher
number of astrocytes in the globus pallidus compared to the
substantia nigra (p < 0.001) and the striatum at ages 2-,
6- and 19-months (p < 0.001) and 27-months (p < 0.05;
Supplementary Figure S3iii).
Alterations in Numbers of Ferritin- and Glial-
Immunopositive Cells With Aging
Ferritin-immunopositive cells were less abundant in the
substantia nigra at 19-months of age compared to that
at 2- and 6-months (p < 0.05, p < 0.001, respectively),
while the cell numbers at 27-months were lower relative
to that at 6-months (p < 0.05) but not at 2-months
(Figure 6Bi). On the contrary, the globus pallidus (p < 0.001)
showed significantly enriched ferritin-immunopositive cell
populations at 19- and 27-months compared to that at
younger ages, 2- and 6-months. As expected, striatal ferritin-
immunoreactive cells were augmented at aged 6-, 19- and
27-months relative to that at 2-months (p < 0.05, p < 0.001 and
p< 0.001, respectively).
In the substantia nigra, microglial cells were found to be
higher in the 2- (p < 0.05), 19- (p < 0.05) and 27-months
old mice (p < 0.001) compared to that in the 6-months old
(Figure 6Bii). The globus pallidus (p < 0.01) and striatum
(p< 0.05) demonstrated a highermicroglial-immunopositivity at
aged 27-months compared to 6-months, while striatal microglial
cells were also higher compared to 2-months (p< 0.05).
GFAP-immunostaining revealed significantly higher
astrocytes in the 2-month and 19-month-old mice compared to
that in the 6-month old, in the substantia nigra (Figure 6Biii).
The astrocytes were observed to be augmented in the 19-
and 27-month-old in relation to the 6-month-old mice. In
the globus pallidus, astrocytes were significantly enriched at
27-month (p < 0.05) compared to both 2- and 6-month-old
mice. Striatal astrocyte (p < 0.001) content was higher in the
19- and 27-month old compared to the 2- and 6-month old. Also,
astrocytic staining was significantly higher at aged 27-month
relative to 19-month (p< 0.05).
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FIGURE 5 | Graphs showing SRXRF measured changes in the levels of (i) elemental iron (Fe), (ii) copper (Cu), and (iii) zinc (Zn) in the substantia nigra, globus
pallidus, striatum, cingulate cortex and ventral hippocampus with increasing age. Significance level at ∗p < 0.05; ∗∗p < 0.01 and ∗∗∗p < 0.001, compared to
2-month, #p < 0.05; ##p < 0.01; and ###p < 0.001, compared to 6-month. Iron and zinc were log-transformed. Values are mean ± standard deviation (SD;
n = 4/age).
Relationships Between Cell-Immunoreactivities and
Metals in the Basal Ganglia
Association of Brain Iron to Ferritin-Immunoreactivity
As ferritin is an iron-sequestering protein, we correlated
ferritin-immunoreactivity and iron levels. Higher iron levels
were generally associated with attenuated levels of ferritin-
immunoreactive cells in the substantia nigra, albeit significance
at p < 0.05 was not reached (R2 = −0.23, p = 0.0572). On the
contrary, in the globus pallidus (R2 = 0.86, p = 2.59 × 10−7)
and striatum (R2 = 0.68, p = 8.77 × 10−5), ferritin levels were
positively correlated to iron concentrations (Figure 7i).
We also formulated an iron to ferritin ratio to assess how
both measures change in relation to one another in the basal
ganglia with age. A significant increase in the iron:ferritin ratio
(Supplementary Figure S4i) was observed at aged 19- and
27-months compared to 2- and 6-months, in the substantia nigra
(p < 0.01, p < 0.05, respectively) and globus pallidus (p < 0.05,
p < 0.01, p < 0.001, respectively). In the striatum, a higher iron:
ferritin ratio was observed only at 27-months (p < 0.05) of age
relative to 2- and 6-months.
Ferritin- and Glial-Immunoreactive Cells
Since glial cells predominantly contain light-chain ferritin, we
correlated ferritin with Iba1 or GFAP immunoreactivities and
found heterogeneity in associations between ferritin and glial
cells in the basal ganglia (Figure 7). Higher levels of ferritin
immunopositive cells were correlated to lower levels of microglia
in the substantia nigra (R2 = −0.25, p = 0.0475), while a
positive association was observed between ferritin and microglia
in the globus pallidus (R2 = 0.55, p = 0.001) and striatum
(R2 = 0.46, p = 0.0041; Figure 7ii). Interestingly, a similar trend
was apparent for ferritin and astrocytes (Figure 7iii), where
ferritin was negatively correlated to astrocytes in the substantia
nigra (R2 = −0.54, p = 0.0013) but positively correlated to
astrocytes in the globus pallidus (R2 = 0.44, p = 0.0051) and
striatum (R2 = 0.66, p = 0.0001).
Relationship Between Metal Levels and Glia Numbers
We reasoned that glia, particularly those that surround neurons,
may accumulate metals to maintain homeostasis locally to
protect neurons from metal-induced oxidative stress, leading us
to a plausible examination of the association betweenmetal levels
and glial cell numbers. Higher levels of iron were associated with
higher number of microglia in the globus pallidus (R2 = 0.57,
p = 0.0008) and striatum (R2 = 0.48, p = 0.0028), but not
in the substantia nigra (R2 = 0.17, p = 0.1084; Figure 8i). A
positive linear correlation (Figure 8ii) was observed between
iron levels and astrocytes in substantia nigra (R2 = 0.37,
p = 0.013), globus pallidus (R2 = 0.49, p = 0.0025) and striatum
(R2 = 0.84, p = 5.26× 10−7).
While generally, a higher concentration of copper was related
to higher numbers of microglia in the basal ganglia, significance
was only reached in the globus pallidus (R2 = 0.43, p = 0.0057),
and not in other basal ganglia regions (Figure 8iii). There
was also a generally positive association between copper and
astrocytes in the substantia nigra (R2 = 0.21, p = 0.0755),
globus pallidus (R2 = 0.16, p = 0.1189) and in the striatum
(R2 = 0.24, p = 0.0564), albeit not significant at the
p< 0.05 level (Figure 8iv).
A trend of negative relationship between zinc levels
and microglia was apparent in the substantia nigra
(R2 = −0.22, p = 0.0683), but a significant positive association
Frontiers in Aging Neuroscience | www.frontiersin.org 7 December 2019 | Volume 11 | Article 351
Ashraf et al. Metals in Aging Mouse Brain
FIGURE 6 | (A) Typical immunohistochemical stained images of ferritin in the globus pallidus with hematoxylin-eosin counterstaining (purple) of the cell nuclei at
different ages. Scale bar: 100 µm. (B) Quantitative immunohistochemical analysis of (i) ferritin-, (ii) Iba1 (microglia)- and (iii) GFAP (astrocytes)-immunopositive cells
in the basal ganglia in mice aged 2-, 6-, 19- and 27-months. Significance level at ∗p < 0.05 and ∗∗∗p < 0.001, compared to 2-month; #p < 0.05; ##p < 0.01; and
###p < 0.001, compared to 6-month and β, p < 0.05 compared to 19-months. Ferritin, Iba1, and GFAP data were log-transformed. Values are mean ± standard
deviation (SD) (n = 4/age).
FIGURE 7 | Linear regression analysis was performed to examine the association between ferritin with iron (i), microglia (ii) and astrocytes (iii) in the basal ganglia.
The regression equation for each graph, correlation coefficient (R2) and p-value (n = 16) for each analysis is noted.
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FIGURE 8 | Linear regression analysis was performed to assess the association between (i) iron and microglia, (ii) iron and astrocytes, (iii) copper and microglia,
(iv) copper and astrocytes in the basal ganglia. The regression equation for each graph, correlation coefficient (R2) and p-value (n = 16) for each analysis is noted.
was demonstrated in the globus pallidus (R2 = 0.37,
p = 0.0132; Figure 9i). Moreover, a higher level of zinc was
associated with higher numbers of astrocytes (R2 = 0.27,
p = 0.040; Figure 9ii).
Aging-Associated Changes in Metal to Glia Ratio
Aging is associated with perturbed brain metal homeostasis and
altered glial biology and therefore the aim of the present study
was to evaluate how metal levels change in relation to the glia
in the basal ganglia with advancing age. To investigate this, we
calculated metal to glia ratios to elucidate the changing metal
concentrations relative to glia (Supplementary Figure S4).
The iron:microglia ratio was augmented in the substantia
nigra in 19- (p < 0.01) and 27-month (p < 0.05) old
compared to that in 2-month-old mice (Supplementary Figure
S4ii). Similarly, the globus pallidus demonstrated a higher
iron:microglia ratio at aged 19- and 27-months, relative to
that at 2-months (p < 0.001) and 6-months (p < 0.01,
p < 0.001). The striatum also exhibited a higher iron:microglia
ratio at aged 19- and 27-months compared to that at 2-months
and a lower iron:microglia ratio was observed at 6-months
compared to 19-months. The iron:astrocytes ratio was elevated
in the substantia nigra and globus pallidus in the 19-
(p < 0.05, p < 0.001, respectively) and 27-month-old mice
(p < 0.001) compared to the 2-month-old (Supplementary
Figure S4iii). Moreover, aged 19- (p < 0.001) and 27-
month-old (p < 0.01) mice showed a higher iron:astrocytes
ratio in the globus pallidus compared to in the younger 6-
month-old mice. Meanwhile, the striatal iron:astrocytes ratio
was found to be significantly lower in the older 19- and
27-months mice in relation to the younger aged 2 and
6-months old mice (p < 0.001, p < 0.05 and p < 0.001,
p< 0.001, respectively).
Copper:microglia ratios were similar across the younger
and older aged groups in the basal ganglia (Supplementary
Figure S4iv), however, the copper:astrocytes ratio was attenuated
at ages 19- and 27-month-old compared to their younger
counterparts (Supplementary Figure S4v), 2-month (p< 0.001)
and 6-month old (p < 0.01, p < 0.001). The substantia
nigra exhibited increased zinc:microglia at 6-months vs. 2-
(p < 0.01), 19- (p < 0.05) and 27-months (p < 0.05,
Supplementary Figure S4vi), a similar pattern to that for
the nigral zinc:astrocytes ratio (Supplementary Figure S4vii).
An augmented striatal zinc:astrocytes profile was found in
the 2-month old (p < 0.001) compared to the 6- and 19-
month-old, while a lower zinc:astrocytes ratio was evident
at 19- (p < 0.01) and 27-months (p < 0.001) compared
to 6-months.
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FIGURE 9 | Linear regression analysis was performed to assess the association between (i) zinc and microglia, (ii) zinc and astrocytes in the basal ganglia. The
regression equation for each graph, correlation coefficient (R2) and p-value (n = 16) for each analysis is noted.
DISCUSSION
We demonstrate altered metal deposition and glia dystrophy in
the basal ganglia regions with increasing age, which could explain
the susceptibility of selected brain regions to neurodegenerative
disease. Most noticeably, increased heterogeneity and differential
distributions of the metals in the various brain regions with
aging was apparent. Specifically, iron was highly enriched in
the basal ganglia and exhibited age-related increases. Meanwhile,
copper and zinc seemed to show modest increments in their
concentration confined to the globus pallidus with aging, with
zinc appearing to be enriched in nerve bundles. Moreover,
levels of microglia and astrocytes increased as a function of
age in the basal ganglia, but the aged brain showed dystrophic
glia, reminiscent of senescence. Since aging is associated with
a perturbed BCSFB, metal compositions were observed to be
altered, particularly striking was copper deposition at the choroid
plexus/ventricles. Taken together, we demonstrate that changes
in brain barrier permeability and glial dystrophy with aging may
induce differential regional content of various metals and are a
hallmark of the aging brain.
Iron
Consistent with previous reports including our own (Walker
et al., 2016), iron was present at higher concentrations in
the substantia nigra and globus pallidus compared to that
in the striatum, cortex, and hippocampus at the older ages
(Hallgren and Sourander, 1958). The iron levels increased with
age predominantly in the basal ganglia, suggesting iron to be an
age-dependent enriched metal in the brain (Connor et al., 1990).
The augmented iron levels can be attributed to the constant
delivery of iron into the brain and decreased release of iron
into the blood via the BBB and BCSFB (Burdo and Connor,
2003). It is tempting to postulate that iron may be drained
from the cerebrospinal fluid (CSF) via the lymphatic system
(Ashraf et al., 2018). Interestingly, an in vitro study showed
the transport of unbound iron from CSF to the blood via
a DMT1-mediated transport mechanism (Wang et al., 2008).
Furthermore, following in vivo exposure of rats to toxic amounts
of manganese, the clearance of iron from the CSF to the
blood was significantly diminished, leading to increased CSF
iron deposition (Wang et al., 2008). Defective iron clearance
as a function of aging may explain the qualitative increases
in ventricular iron in older-aged mice we observed. Moreover,
astrocytes which serve vital functions including transport of
iron across brain-barrier systems and maintenance of brain iron
homeostasis (Kubik and Philbert, 2015; Ashraf et al., 2018),
demonstrated qualitatively age-related decreases in the regions
close to the BCSFB (fimbria/ventral commissure level) in this
study, reinforcing apparent impaired iron clearance from the
brain with aging.
Usually, elevated iron is consistent with altered expression
levels of iron-binding proteins, especially of ferritin, as its
expression is induced by increased iron (Burdo et al., 1999).
Indeed, increased ferritin mirrors the iron deposition in
the globus pallidus and striatum we observed. However,
a dissociation between iron accumulation and ferritin
upregulation was observed in the aged substantia nigra,
where higher levels of iron were not associated with increased
levels of ferritin as we and others have reported previously
(Benkovic and Connor, 1993; Walker et al., 2016). Ferritin
is composed of 24 subunits of two types, heavy and light
chains, forming a soluble hollow shell capable of storing
up to 4,500 ferric iron atoms (Harrison and Arosio, 1996).
This cellular iron storage protein is present in neurons,
microglia, and oligodendrocytes, with oligodendrocytes being
the highest iron-containing cell in the brain (Benkovic and
Connor, 1993). Interestingly, the detection of ferritin in
astrocytes is unusual, in that astrocytes exhibit weak ferritin
immunoreactivity (Mirza et al., 2000). Heavy chain ferritin
exhibits ferroxidase activity and converts the reactive toxic
ferrous ion to the more stable ferric ion, so that iron can
be stored by light chain ferritin (Muhoberac and Vidal,
2013). Microglia predominantly contain light chain ferritin
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as they are more concerned with scavenging iron (Ashraf
et al., 2018) and have been shown to accumulate more iron
than neurons, with microglia being better scavengers than
astrocytes (Bishop et al., 2011). In the present study, we
found a positive linear correlation between ferritin- and
glial cell-immunoreactive cells in the globus pallidus and
striatum, consistent with a previous report (Schipper et al.,
1998). Interestingly, ferritin immunopositive microglia has
been demonstrated to become more pronounced with age,
whereas neuronal ferritin staining remains unaltered despite
elevated iron as assessed by Perl’s histochemical staining
(Benkovic and Connor, 1993). Elevated iron in neurons, in the
absence of a concomitant increase in neuronal ferritin, may
predispose neurons to iron-induced free radical damage and
ensuing oxidative stress. In the vulnerable aged brain, the role
of glial ferritin in sequestrating and detoxifying iron is even
more paramount.
Negative correlation was observed between ferritin- and
GFAP-immunopositive cells in the substantia nigra. Due to its
exceptionally high iron content, the substantia nigra adopts two
different iron storage systems, one based on ferritin and the
other, on neuromelanin (Tribl et al., 2009), enabling synergistic
regulation of iron homeostasis. However, our age-related
observation of decreased ferritin along with reports signifying
declining neuromelanin content (Tribl et al., 2009; Xing et al.,
2018) in the aged substantia nigra, suggest an increased ferrous
iron pool that can precipitate oxidative stress during brain aging,
contributing to the increased risk of neurodegenerative diseases,
particularly PD, with aging (Dexter et al., 1987; Xu et al., 2018).
We and others have previously reported increased microglial
and astroglial cell numbers with aging in the basal ganglia,
providing evidence for a more primed or inflammatory profile
(Codazzi et al., 2015; Walker et al., 2016; Boisvert et al.,
2018). Aging is associated with chronically elevated levels
of circulating cytokines including TNFα, IL1β and TGFβ,
with glial cells being major driving factors for brain aging
(von Bernhardi et al., 2010). Interestingly, microglial and
astroglial iron homeostasis has been shown to be differentially
regulated by TNFα and TGFβ. Treatment of astrocytes with
pro-inflammatory TNFα induced expression of DMT1 and
suppressed ferroportin expression, while anti-inflammatory
TGFβ-treatment did not affect DMT1 expression but increased
ferroportin expression (Rathore et al., 2012). On the contrary,
treatment of microglia with either TNFα or TGFβ leads to
augmented DMT1 expression together with suppression of
ferroportin. The findings demonstrate that TNFα leads to
iron uptake and retention by both microglia and astrocytes,
while TGFβ promotes iron efflux from astrocytes but increased
microglial iron retention (Rathore et al., 2012). Astrocytes appear
to be amenable to modulation, while microglia are fuelled by
iron to perpetuate inflammation, hastening the aging process
and contributing to increased susceptibility to acquiring the
neurodegenerative disease.
Interestingly, we found an increased iron to microglia ratio
in the basal ganglia, while the iron to astroglia ratio was elevated
in the substantia nigra and globus pallidus but decreased in the
striatum during aging. This could be indicative of the different
roles performed by astrocytes on a regional basis per se. The
nigral astrocytes have been found to be overly sensitive to acute
ischemia compared to other brain regions (Karunasinghe et al.,
2018), and exhibit vulnerability to oxidative insult (Cardoso
et al., 2012, 2014). The aged nigra is associated with both iron and
copper deposition in subsets of astrocytes (Schipper et al., 1998),
rendering these astrocytes inherently prone to perturbations in
metal redox homeostasis. Oxidative inactivation of aconitase, aka
iron-responsive protein-1 (IRP1), which is involved in regulating
cellular iron, in astrocytes has been linked to increased ferrous
iron and hydrogen peroxide production (Cantu et al., 2009),
promoting bioactivation of dopamine and other catechols to
neurotoxic free radicals. Of note, augmented release of IL-1β
and TNFα by iron-loaded microglia induced upregulation
of IRP1, DMT1, hepcidin and transferrin receptor-1 (TfR1)
expression in ventral mesencephalic neurons via production
of reactive oxygen species (ROS), enhancing neuronal iron
accumulation (Xu et al., 2016). Inefficient sequestration of
redox-active iron by aging nigral glia, concomitant with the
dissociation between iron and ferritin upregulation mentioned
above, may predispose the senescent nervous system to
oxidative stress-mediated neurodegeneration (via Fenton
reactions) in Parkinsonism and other neurodegenerative diseases
(Zecca et al., 2004).
While microglia may be unequivocally involved in
perpetuating the generation of ROS in the striatum, astrocytes
may play more of a neuromodulatory role (Pelizzoni et al., 2013).
The declining iron to astroglia ratio in the striatum observed
in the present study could be indicative of a compensatory
response mediated by astrocytes to regulate iron levels (Knott
et al., 1999). Striatal astrocytes are commissioned with the
task of physiological clearance of age-related synaptic debris,
particularly of degenerated dopaminergic neurons (Morales
et al., 2017). Dopaminergic neurons undergo an insidious
degeneration (∼6–8% of cells every decade) during normal
aging while in PD, a loss of 60% of striatal synapses is
evident (Rodriguez et al., 2015). Previous data suggests that
if astrocytes can perform functional trans-autophagy of
cell debris, this should be sufficient to ensure striatal tissue
homeostasis. However, the onset of PD may be characterized
by impaired astroglial trans-autophagy, necessitating microglial
activation to complete the clearance of dopaminergic neuronal
debris, thereby aggravating the onset and progression of PD
(Morales et al., 2017).
As previously documented, microglia and astroglia
demonstrated pronounced morphological changes with aging
in the basal ganglia, where senescent dystrophic glia exhibited
hypertrophic soma and decreased arborization of processes
(Jyothi et al., 2015). The glial cells may undergo aberrant
signaling, leading to age-related metal dyshomeostasis, and
represent a concause in neurodegenerative processes.
Copper
Copper levels were higher in the striatum, cingulate cortex, and
ventral hippocampus compared to the globus pallidus in 6-
month-old mice. The older mice exhibited increases in copper
levels in the globus pallidus compared to 2- and 6-month-old
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mice, as well as high copper levels, were correlated with an
augmented number of microglia. Akin to iron, copper can also
undergo Fenton chemistry and so high copper levels promote
ROS production, and altered copper homeostasis is prevalent
in neurodegenerative diseases (Wang et al., 2010; Zheng et al.,
2010; Zheng and Monnot, 2012). Aging is characterized by a
chronic neuroinflammatory state and interferon γ-stimulated
microglial cells have been associated with augmented copper
uptake accompanied by an expression of the copper importer,
copper transporter-1 (CTR1) particularly in the choroid plexus
(Zheng et al., 2010). Copper was strikingly enriched in the
ventricles with aging in the present study, consistent with
previous observations of increased copper at the choroid plexus
(Fu et al., 2015). It has been suggested that the BCSFB is
the predominant barrier for regulated copper uptake in the
brain (Choi and Zheng, 2009). Astrocytes in the vicinity of
ventricles are in a prime location to balance brain copper
content and achieve detoxification, having access to both
interstitial fluid and CSF (Pushkar et al., 2013). Moreover,
the concentrations of other metals did not reach the striking
levels exhibited by copper with aging, implying that astrocytes
are chiefly involved in regulating brain copper levels. Our
finding of increased ventricular copper deposition is further
strengthened by literature showing augmented genetic and
protein expression levels of copper transporters (e.g., ATP7A)
at the choroid plexus compared to the brain parenchyma
(Choi and Zheng, 2009; Fu et al., 2015). We found attenuated
astrocytic expression close to the ventricles at the level of
ventral commissure/fimbria with aging and concomitant with
astrocytes being intimately involved in sequestrating copper,
age-associated dysregulation of astroglial copper-buffering may
occur and lead to toxic copper accumulation (Zheng and
Monnot, 2012). As increased copper levels have been linked
to reduced neurogenesis (Pushkar et al., 2013) which may be
another contributory factor to the susceptibility of the aged brain
to neurodegenerative diseases.
Zinc
Zinc is a pleiotropic modulator of synaptic plasticity, neuronal
activity, and cognitive processes, with ∼30% of zinc in the brain
existing as the free/chelatable form and stored within synaptic
vesicles of glutamatergic forebrain neurons and the remaining
∼70%, in proteins (Portbury and Adlard, 2017). Zinc levels in
the brain are regulated by metallothioneins, zinc- and iron-like
regulatory proteins (ZIPs) and zinc transporter proteins (ZnTs;
Hennigar and Kelleher, 2012). Zinc is released from presynaptic
vesicles into the synaptic cleft, coincident with glutamate and
regulates e.g., long-term potentiation via activation of N-
methyl-D-aspartate (NMDA) receptors (Takeda and Tamano,
2012). Histochemical staining visualizes free/chelatable zinc,
usually synaptic zinc, has long-established zinc to be highly
localized in nerve bundles and subsequently proved by proton-
induced X-ray emission spectroscopy (Danscher et al., 1985).
Similarly, we observed zinc to be enriched in the stria
medullaris of the thalamus, corpus collosum, the fornix, and the
hippocampal fissure, especially in older aged brains. Further, zinc
accumulation had been shown to be higher in the hippocampus
compared to other brain regions with the exception of the
cerebellum following the administration of radioactive zinc to
rats (Sawashita et al., 1997). This is consistent with the higher
zinc in the ventral hippocampus compared to the substantia
nigra at 6-months of age that we observed and underscores
the importance of zinc in learning and memory consolidation
(Sindreu and Storm, 2011). Zinc levels were also higher in
the globus pallidus than in the substantia nigra at 2-months
of age, albeit comparable to that in the hippocampus. Zinc
has been known to modulate GABAergic transmission in the
globus pallidus (Chen and Yung, 2006) and zinc is likely
to have a major role during neurodevelopment in this brain
region. However, the globus pallidus demonstrated lower zinc
levels compared to the substantia nigra at 6-months of age.
Indirect inputs from the striatal medium spiny neurons to the
substantia nigra pars recta are via the external part of the
globus pallidus and mediated by inhibitory neurons such that
medium spiny neurons excitation further inhibits the thalamus
via this pathway (Frank, 2005). The reversal in the zinc gradient
between the globus pallidus and the substantia nigra as mice
matured from 2 to 6 months of age suggests alterations in
electrical activity/tone of this indirect basal ganglia circuit
during neurodevelopment. We also observed a similar pattern
of increased zinc in the cingulate cortex as mice aged from 2 to
6 months of age, consistent with zinc-containing neurons being
required in brain development to form complex and elaborate
associational network to interconnect the cortex with the limbic
system (Corona et al., 2011).
Brain zinc levels have been reported to be increased with aging
in both rats (Sawashita et al., 1997) and in man (Markesbery
et al., 1984). We also observed augmented zinc levels in the
globus pallidus of 27-months old mice compared to 2-, 6- and
19-months old mice. Interestingly, zinc accumulation has been
reported in the globus pallidus in the 6-hydroxydopamine rat
model of PD (Tarohda et al., 2005) and in the substantia nigra
and striatum of PD subjects (Dexter et al., 1989). Thus, the
augmented zinc in the globus pallidus of very old mice suggests
zinc dysregulation may be another factor in aging being the
major risk factor for neurodegenerative disease. While we did
not observe significantly increased hippocampal zinc levels, this
has been observed in aging rats and zinc chelation therapy was
shown to attenuate deficits in synaptic plasticity (Shetty et al.,
2017). Note, the discrepancy may arise as SRXRFmaps elemental
zinc content, rather than free/chelatable zinc, which is often the
form detected by other zinc measurement techniques.
Zinc has primarily been known to be associated with neuronal
function, however, glial cells are commissioned with the task
of maintaining zinc homeostasis, thereby maintaining optimal
synaptic signaling (Hancock et al., 2014). We found a significant
association between zinc and glial cells in the globus pallidus.
Indeed, astrocytes accumulate zinc (Nolte et al., 2004) via
expression of the zinc transporter, ZIP14 (Bishop et al., 2010),
enabling astrocytes to maintain glutamatergic and GABAergic
synaptic transmission (Hancock et al., 2014). Also, microglia
can directly uptake zinc via another zinc transporter, ZIP1,
which serves as a trigger for sequential microglial activation
(Higashi et al., 2011). The glial senescence observed in this study
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may induce aberrant connectivity at the tri-partite synapse by
enhancing zinc dyshomeostasis with aging.
During neurodevelopment (from 2 to 6 months of
age), the increased zinc to glial ratio observed may reflect
increased availability of zinc to neurons and glia for
synaptogenesis/synaptic pruning. In humans, peak synaptic
density has been demonstrated to occur in mid-childhood (Liu
et al., 2012), with synaptic pruning extending to a third decade of
life (Petanjek et al., 2011). However, the ratio of zinc to astroglia
was reduced in the basal ganglia at the older ages which may
be attributed to the age-associated astrogliosis observed. Thus,
a situation of functional zinc deficiency may be induced, as
opposed to zinc excess as suggested above, regardless, either
scenario may contribute to the synaptic dysfunction observed in
aging (Szewczyk, 2013).
CONCLUSION
Metal dyshomeostasis and the presence of a low-grade chronic
inflammation owing to dystrophic glial cells are pervasive
features of normal aging, rendering the brain susceptible to
neurodegenerative diseases.
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